Cargando…
Study protocol and statistical analysis plan for the 20% Human Albumin Solution Fluid Bolus Administration Therapy in Patients after Cardiac Surgery-ll (HAS FLAIR-II) trial
Background: Fluid bolus therapy with 20% albumin may shorten the duration of vasopressor therapy in patients after cardiac surgery. Objective: To describe the study protocol and statistical analysis plan for the 20% Human Albumin Solution Fluid Bolus Administration Therapy in Patients after Cardiac...
Autores principales: | Wigmore, Geoffrey, Deane, Adam M., Anstey, James, Bailey, Michael, Bihari, Shailesh, Eastwood, Glenn, Ghanpur, Rashmi, Maiden, Matthew J., Presneill, Jeffrey J., Raman, Jaishankar, Bellomo, Rinaldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692638/ https://www.ncbi.nlm.nih.gov/pubmed/38047012 http://dx.doi.org/10.51893/2022.4.OA1 |
Ejemplares similares
-
Rapid 500 mL albumin bolus versus rapid 200 mL bolus followed by slower continuous infusion in post-cardiac surgery patients: a pilot before-and-after study
por: Yanase, Fumitaka, et al.
Publicado: (2023) -
Physiological changes after fluid bolus therapy in sepsis: a systematic review of contemporary data
por: Glassford, Neil J, et al.
Publicado: (2014) -
Temperature and haemodynamic effects of a 100 mL bolus of 20% albumin at room versus body temperature in cardiac surgery patients
por: Yanase, Fumitaka, et al.
Publicado: (2023) -
Albumin as a drug: its biological effects beyond volume expansion
por: Bihari, Shailesh, et al.
Publicado: (2023) -
Haemodynamic effect of a 20% albumin fluid bolus in post-cardiac surgery patients
por: Cutuli, Salvatore L., et al.
Publicado: (2023)